The German office of King & Spalding, opened in October 2007, focuses on the following areas of law:
The range of services offered by our regulatory and real estate/capital markets practices include providing regulatory and tax counsel in the establishment of investment companies and the issuing and administration of public and special capital funds. We advise real estate/investment companies on regulatory, tax and all related issues in the structuring and optimization of their domestic and foreign activities, and the development of highly complex foreign and German products and structures. Another focus is on counseling real estate and other investors in their German and worldwide real estate and commercial transactions and financings. Our team advises real estate companies, open and closed funds, institutional investors and asset managers in all areas of real estate law, including asset management.
In addition, we have established in Frankfurt a specialized German and international arbitration practice that works with the firm’s global market-leading international arbitration group. Clients both in and outside of Germany trust us to represent them before arbitration courts. In addition to handling cross-border corporate law disputes in various venues and courts, we offer specialized expertise in arbitration procedures that enforce foreign investment rights.
With the addition of a German Life Sciences practice in 2014, we have been expanding our capabilities in the healthcare, food, pharmaceutical and medical devices sectors. Our lawyers counsel clients in all areas of EU regulatory, compliance, medical devices, pharmaceutical and food law. The German team also represents Life Sciences clients in litigation cases before German and European courts including the General Court and the Court of Justice of the European Union. The Frankfurt lawyers are an integral part of our international market-leading FDA & Life Sciences practice and the firm's international Food & Beverage group.